For the year ending 2025-12-31, TARA has $209,468K in assets. $13,056K in debts. $49,657K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 49,657 | |||
| Marketable debt securities | 105,897 | |||
| Prepaid expenses and other current assets | 3,950 | |||
| Total current assets | 159,504 | |||
| Restricted cash, non-current | 745 | |||
| Marketable debt securities, non-current | 42,336 | |||
| Property and equipment, gross | 2,227 | |||
| Less accumulated depreciation | 1,468 | |||
| Property and equipment, net | 759 | |||
| Operating lease right-of-use asset | 3,174 | |||
| Other assets | 2,950 | |||
| Total assets | 209,468 | |||
| Accounts payable | 3,468 | |||
| Accrued expenses and other current liabilities | 6,229 | |||
| Operating lease liability | 1,242 | |||
| Total current liabilities | 10,939 | |||
| Operating lease liability, non-current | 2,117 | |||
| Total liabilities | 13,056 | |||
| Common stock, 0.001 par value, authorized 100,000,000 shares common stock, 53,587,260 and 35,044,772 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 54 | |||
| Additional paid-in capital | 498,687 | |||
| Accumulated deficit | -302,419 | |||
| Accumulated other comprehensive income (loss) | 90 | |||
| Total stockholders equity | 196,412 | |||
| Total liabilities and stockholders equity | 209,468 | |||
Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. (TARA)